Pharmacological manipulation of calcium-sensing receptor: Prospect as anabolic therapy for postmenopausal osteoporosis

Drugs of the Future

Volumn 34, Issue 10, 2009, Pages 803-809

  Trivedi, R ^a   Mithal, A ^b   Chattopadhyay, N ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b INDRAPRASTHA APOLLO HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 BENZYLPYRROLIDINE DERIVATIVE; 2 CHLORO 6 [3 [1,1 DIMETHYL 2 (2 NAPHTHYL)ETHYLAMINO] 2 HYDROXYPROPOXY]BENZONITRILE; 4 ARYL 1H QUINAZOLIN 2 ONE DERIVATIVE; ANABOLIC AGENT; CALCIUM SENSING RECEPTOR; CINACALCET; ESTRADIOL; N [3 (2 CHLOROPHENYL)PROPYL] 1 (3 METHOXYPHENYL)ETHYLAMINE; N1 ARYLSULFONYL N2 [1 (1 NAPHTHYL)ETHYL] 1 ,2 DIAMINOCYCLOHEXANE DER; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; RECOMBINANT PARATHYROID HORMONE; RONACALERET; STRONTIUM RANELATE; UNCLASSIFIED DRUG;

BONE DENSITY; CLINICAL TRIAL; DRUG DESIGN; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; FRAGILITY FRACTURE; HORMONAL THERAPY; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPERPARATHYROIDISM; NAUSEA; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PARATHYROID GLAND; PARATHYROID HORMONE RELEASE; PARATHYROID HYPERPLASIA; PHARMACOPHORE; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN FUNCTION; REVIEW;

EID: 84930539071     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2009.034.10.1415096     Document Type: Review

References (53)

1. Brown, E.M. Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers. Physiol Rev 1991, 71(2): 371-411.
2. Brown, E.M., MacLeod, R.J. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001, 81(1): 239-7.
3. Hawkins, D., Enyedi, P., Brown, E. The effects of high extracellular Ca2+ and Mg2+ concentrations on the levels of inositol 1,3,4,5-tetrakisphosphate in bovine parathyroid cells. Endocrinology 1989, 124(2): 838-44.
4. Brown, E.M., Gamba, G., Riccardi, D. et al. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993, 366(6455): 575-80.
5. Brown, E.M. Clinical lessons from the calcium-sensing receptor. Nat Clin Pract Endocrinol Metab 2007, 3(2): 122-33.
6. Hofer, A.M, Brown, E.M. Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol 2003, 4(7): 530-8.
7. Chattopadhyay, N., Brown, E.M. Role of calcium-sensing receptor in mineral ion metabolism and inherited disorders of calcium-sensing. Mol Genet Metab 2006, 89(3): 189-202.
8. Nemeth, E.F., Steffey, M.E., Hammerland, L.G., Hung, B.C., Van Wagenen, B.C., DelMar, E.G., Balandrin, M.F. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 1998, 95(7): 4040-5.
9. Soudijn, W., Van Wijngaarden, I., Ijzerman, A.P. Allosteric modulation of G protein-coupled receptors: Perspectives and recent developments. Drug Discov Today 2004, 9(17): 752-8.
10. Nemeth, E.F., Delmar, E.G., Heaton, W.L. et al. Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone. J Pharmacol Exp Ther 2001, 299(1): 323-31.
11. Dempster, D.W., Cosman, F., Parisien, M., Shen, V., Lindsay, R. Anabolic actions of parathyroid hormone on bone. Endocr Rev 1993, 14(6): 690-709.
12. Trivedi, R., Mithal, A., Chattopadhyay, N. Anabolics in osteoporosis: The emerging therapeutic tool. Curr Mol Med 2009, Epud ahead of print.
13. Fox, J. Developments in parathyroid hormone and related peptides as bone-formation agents. Curr Opin Pharmacol 2002, 2(3): 338-44.
14. Verhaar, H.J., Lems, W.F. PTH-analogs: Comparable or different? Arch Gerontol Geriatr 2009 ,49(2): e130-2.
15. Kimmel, D.B., Bozzato, R.P., Kronis, K.A., Coble, T., Sindrey, D., Kwong, P., Recker, R.R. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats. Endocrinology 1993, 132(4): 1577-84.
16. Parfitt, A.M. Bone and plasma calcium homeostasis. Bone 1987, 8(Suppl. 1): S1-8.
17. Parfitt, A.M. Plasma calcium control at quiescent bone surfaces: A new approach to the homeostatic function of bone lining cells. Bone 1989, 10(2): 87-8.
18. Raisz, L.G. Physiology and pathophysiology of bone remodeling. Clin Chem 1999, 45(8, Pt. 2): 1353-8.
19. Dvorak, M.M., Siddiqua, A., Ward, D.T., Carter, D.H., Dallas, S.L., Nemeth, E.F., Riccardi, D. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci U S A 2004, 101(14): 5140-5.
20. Dvorak, M.M., Riccardi, D. Ca2+ as an extracellular signal in bone. Cell Calcium 2004, 35(3): 249-55.
21. Yamaguchi, T., Chattopadhyay, N., Kifor, O., Ye, C., Vassilev, P.M., Sanders, J.L., Brown, E.M. Expression of extracellular calcium-sensing receptor in human osteoblastic MG-63 cell line. Am J Physiol Cell Physiol 2001, 280(2): C382-93.
22. Shalhoub, V., Grisanti, M., Padagas, J. et al. In vitro studies with the calcimimetic, cinacalcet HCI, on normal human adult osteoblastic and osteoclastic cells. Crit Rev Eukaryot Gene Expr 2003, 13(2-4): 89-106.
23. Christiansen, B., Hansen, K.B., Wellendorph, P., Brauner-Osborne, H. Pharmacological characterization of mouse CPRC6A, an L-alpha-amino-acid receptor modulated by divalent cations. Br J Pharmacol 2007, 150(6): 798-807.
24. Trivedi, R., Mithal, A., Chattopadhyay, N. Recent updates on the calcium-sensing receptor as a drug target. Curr Med Chem 2008, 15(2): 178-86.
25. Kameda, T., Mano, H., Yamada, Y. et al. Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells. Biochem Biophys Res Commun 1998, 245(2): 419-22.
26. Lorget, F., Kamel, S., Mentaverri, R., Wattel, A., Naassila, M., Maamer, M., Brazier, M. High extracellular calcium concentrations directly stimulate osteoclast apoptosis. Biochem Biophys Res Commun 2000, 268(3): 899-903.
27. Lord, B.I., Testa, N.G., Hendry, J.H. The relative spatial distributions of CFUs and CFUc in the normal mouse femur. Blood 1975, 46(1): 65-72.
28. Gong, J.K. Endosteal marrow: A rich source of hematopoietic stem cells. Science 1978, 199(4336): 1443-5.
29. House, M.G., Kohlmeier, L., Chattopadhyay, N. et al. Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res 1997, 12(12): 1959-70.
30. Sharan, K., Siddiqui, J.A., Swarnkar, G., Chattopadhyay, N. Role of calcium-sensing receptor in bone biology. Indian J Med Res 2008, 127(3): 274-86.
31. Marie, P.J. Strontium ranelate: A novel mode of action optimizing bone formation and resorption. Osteoporos Int 2005, 16(Suppl. 1): S7-10.
32. Chattopadhyay, N., Quinn, S.J., Kifor, O., Ye, C., Brown, E.M. The calcium-sensing receptor (CaR) is involved in strontium ranelote-induced osteoblast proliferation. Biochem Pharmacol 2007, 74(3): 438-47.
33. Mentaverri, R., Yano, S:, Chattopadhyay, N. et al. The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis. FASEB J 2006, 20(14): 2562-4.
34. Hofbauer, L.C., Heufelder, A.E. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med 2001, 79(5-6): 243-53.
35. Bonnelye, E., Chabadel, A., Saltel, F., Jurdic, P. Dual effect of strontium ranelate: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 2008, 42(1): 129-38.
36. Li, Z., Lu, W.W., Deng, L. et al. The morphology and lattice structure of bone crystal after strontium treatment in goats. J Bone Miner Metab 2009, Epub ahead of print.
37. Nemeth, E.F. The search for calcium receptor antagonists (calcilytics). J Mol Endocrinol 2002, 29(1): 15-21.
38. Balan, G., Bauman, J., Bhattacharya, S. et al. The discovery of novel calcium sensing receptor negative allosteric modulators. Bioorg Med Chem Lett 2009, 19(12): 3328-32.
39. Fitzpatrick L., Brennan, E., Kumar, S. et al. Ronacaleret, a novel calcium-sensing receptor antagonist, demonstrates potential as an oral bone-forming therapy in healthy postmenopausal women. J Bone Miner Res 2008, 23(Suppl. S): Abst 1174.
40. Paget, S. The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev 1989, 8(2): 98-101.
41. Chattopadhyay, N. Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy. Am J Physiol Endocrinol Metab 2006, 290(5): E761-70.
42. Grill, V., Ho, P., Body, J.J. et al. Parathyroid hormone-related protein: Elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 1991, 73(6): 1309-15.
43. Brandt, D.W., Pandol, S.J., Deftos, L.J. Calcium-stimulated parathyroid hormone-like protein secretion: Potentiation through a protein kinase-C pathway. Endocrinology 1991, 128(6): 2999-3004.
44. Naveh-Many, T., Rahamimov, R., Livni, N., Silver, J. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 1995, 96(4): 1786-93.
45. Wernerson, A., Widholm, S.M., Svensson, O., Reinholt, F.P. Parathyroid cell number and size in hypocalcemic young rats. APMID 1991, 99(12): 1096-102.
46. Kessler, A., Faure, H., Roussanne, M.C., Ferry, S., Ruat, M., Dauban, P., Dodd, R.H. N′-Arylsulfonyl-N2-(1-(1-naphthyl)ethyl)-1,2- diaminocyclohexans: A new class of catalytic agents acting on the calcium-sensing receptor. ChemBioChem 2004, 5(8): 1131-6.
47. Petrel, C., Kessler, A., Dauban, P., Dodd, R.H., Rognan, D., Ruat, M. Positive and negative allosteric modulators of the Ca2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain. J Biol Chem 2004, 279(18): 18990-7.
48. Arey, B.J., Seethala, R., Ma, Z. et al. A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo. Endocrinology 2005, 146(4): 2015-22.
49. Beerli, R., Tommasi, R.A., Weiler, S., Widler, L. Chem Abstr 2002, 138: 39293.
50. Altmann, E., Beerli, R., Gerspacher, M., Renaud, J., Weiler, S., Widler, L. (Novartis AG; Novartis Pharma GmbH). Aryl-quinazoline/aryl-2aminophenyl methanone derivatives. WO 2004056365.
51. Yang, W., Wang, Y., Roberge, J.Y. et al. Discovery and structure-activity relationships of 2-benzylpyrrolidine-substituted aryloxypropanols as calcium-sensing receptor antagonists. Bioorg Med Chem Lett 2005, 15(4): 1225-8.
52. Yang, W., Ruan, Z., Wang, Y. et al. Discovery and structure-activity relationships of trisubstituted pyrimidines/pyridines as novel calcium-sensing receptor antagonists. J Med Chem 2009, 52(4): 1204-8.
53. Shcherbakova, I., Balandrin, M.F., Fox, J., Ghatak, A., Heaton, W.L., Conklin, R.L. 3H-Quinazolin-4-ones as a new catalytic template for the potential treatment of osteoporosis. Bioorg Med Chem Lett 2005, 15(6): 1557-60.